Bruce Greenberg - 12 Aug 2024 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Interim Chief Financial Officer
Signature
/s/ Bruce Greenberg
Issuer symbol
ALDX
Transactions as of
12 Aug 2024
Net transactions value
-$51,313
Form type
4
Filing time
14 Aug 2024, 16:24:15 UTC
Previous filing
17 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Sale $51,313 -10,834 -7.9% $4.74 126,382 12 Aug 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards.
F2 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $4.46 to $5.12. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Includes 7,062 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan.

Remarks:

Interim Chief Financial Officer